Tiliroside is a new potential therapeutic drug for osteoporosis in mice
Cited by 11
Related Papers
Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation
|Nature Communications|2016|588
Pseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen Species
|Theranostics|2019|252
Oroxylin A reduces osteoclast formation and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation
|Biochemical Pharmacology|2021|91
EGFL7 Is Expressed in Bone Microenvironment and Promotes Angiogenesis via ERK, STAT3, and Integrin Signaling Cascades
|Journal of Cellular Physiology|2014|52